Navigation Links
Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management
Date:9/21/2009

Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste. Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Irvine, CA (PRWEB) September 21, 2009 -- Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste.

Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Vestara's EcoRex® Automated Pharmaceutical Waste Management System utilizes barcode technology already widely used in hospitals to track drug utilization that prevents medication errors and a proprietary, continuously updated database of more than 180,000 National Drug Code (NDC) products, to instantly categorize pharmaceutical waste at time of presentation. By automating the identification and sorting of different types of residual drugs, empty containers, and each hospital's unique admixtures, EcoRex® eliminates the human error and potential cross contamination inherent in manual sorting of pharmaceutical waste to reduce negative impact on the environment. Just as important, relevant data and an audit trail are provided in the form of comprehensive reports for client records.

MedClean® Series Systems enable hospitals and other medical facilities to treat and dispose of their RMW stream and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner. MedClean provides a state-of-the-art on-site treatment solution for each end user through its full line of On-Demand Container, Mobile and in-house, fixed systems. MedClean's solutions provide significant advantages for hospital customers compared to other approaches, including lower costs, reduced risk and protection of host communities and the overall environment. A single MedClean Container system can treat 1 million pounds of RMW per year, in addition to handling confidential document destruction, with a smaller footprint required compared to multiple vendors handling different tasks for a hospital.

Working together, Vestara and MedClean bring unique technologies to a common customer base, addressing the toughest waste mitigation issues facing hospitals today.

Please visit booth # 419 at the 2009 ASHES Conference in Reno, NV, September 21-22, 2009, to learn more about the Vestara-MedClean Technologies partnership.

About Vestara
Vestara, headquartered in Irvine, CA, provides proprietary technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper waste streams. Vestara's solutions not only assure clients will be compliant with all federal and state laws, but that they will experience a more efficient health system workforce and true cost savings in managing pharmaceutical waste. Most importantly, clients will play a critical role in preserving our precious environment. To learn more, visit www.vestara.com.

About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

# # #

Read the full story at http://www.prweb.com/releases/2009/09/prweb2870584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vestara Announces Agreement with Leading Environmental "Champion for Change" Company Amerinet
2. MedClean Technologies Inc. Announces New Ticker Symbol
3. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
4. MedClean Technologies, Inc. Announces $1 Million Order
5. MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
6. MedClean Technologies, Inc. Approved in New Jersey
7. MedClean Technologies Announces Results of Private Exchange Offer
8. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
9. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
10. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
11. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... August 18, 2017 — ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , According ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Dawn ... is inaugurating a new charity drive to generate community support for efforts to educate ... into cures and treatments for all types of cancer. , Each day in ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, ... communities in east Texas, is launching a regional charity effort to provide publicity ... 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning firm that serves residential and commercial clients in the greater Houston region, ... raise community support for the fight against cancer. , Founded by Tony and ...
(Date:8/18/2017)... ... August 18, 2017 , ... With over ... in bioidentical hormone replacement therapy and integrative medicine, has become a frontrunner for ... aging, such as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... Aug. 7, 2017  Endo International plc (NASDAQ: ... to resolve virtually all known U.S. mesh product liability ... resolve the known remaining U.S. claims at reasonable values. ... in the fourth quarter of 2017 and continuing through ... second quarter 2017 results, the Company intends to increase ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
Breaking Medicine Technology: